Keywords: پرواریتریوم; Atrial flutter; Chemical ablation; Proarrhythmia; Uncommon flutter; Vein of Marshall;
مقالات ISI پرواریتریوم (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: پرواریتریوم; Biventricular implantable cardioverter-defibrillator; Cardiac resynchronization; Device programming; Proarrhythmia; Ventricular tachycardia;
Keywords: پرواریتریوم; CRT; Proarrhythmia; VT storm;
Keywords: پرواریتریوم; Safety pharmacology; Proarrhythmia; Torsades de pointes; Simulation;
Keywords: پرواریتریوم; Antiarrhythmic drugs; Proarrhythmia; Atrial specific antiarrhythmics; Personalised medicine;
Keywords: پرواریتریوم; Supraventricular tachycardia; Wolff-Parkinson-White syndrome; Flecainide; Incessant orthodromic AV reentrant tachycardia; Proarrhythmia;
Keywords: پرواریتریوم; Fluconazole; Voriconazole; Dispersion of repolarization; Proarrhythmia; Sudden cardiac death
Keywords: پرواریتریوم; Pilsicainide; Proarrhythmia; Renal dysfunction; QRS interval; QTc interval;
Keywords: پرواریتریوم; Citalopram; Escitalopram; Haloperidol; Dispersion of repolarization; Proarrhythmia; Sudden cardiac death;
Keywords: پرواریتریوم; QTc interval; proarrhythmia; pharmacokinetic/pharmacodynamics models; drug interactions; clinical trial simulations; terfenadine;
Keywords: پرواریتریوم; Long-QT Syndrome; GS-458967; Late Na current; Proarrhythmia;
Keywords: پرواریتریوم; AAC; amino acid coding; AF; atrial fibrillation; BMI; body mass index; ECG; electrocardiogram; ESP; Exome Sequencing Project; GWAS; genome-wide association study; IQR; interquartile range; LVEDD; left ventricular end-diastolic diameter; LVEF; left ventric
Keywords: پرواریتریوم; AAD; antiarrhythmic drug; AV; atrioventricular; BS; Brugada syndrome; ECG; electrocardiographic/electrocardiogram; ECMO; extracorporeal membrane oxygenator; ICD; implantable cardioverter-defibrillator; QTc; corrected QT; SD; sudden death; SND; sinus node
Initiation and outcomes with Class Ic antiarrhythmic drug therapy
Keywords: پرواریتریوم; Atrial fibrillation; Antiarrhythmic medication; Flecainide; Propafenone; Exercise stress testing; Proarrhythmia;
CiPA challenges and opportunities from a non-clinical, clinical and regulatory perspectives. An overview of the safety pharmacology scientific discussion
Keywords: پرواریتریوم; Comprehensive In-Vitro Proarrhythmia assay; CiPA; hERG; Multiple cardiac ion channels; Proarrhythmia; QTc; Torsade de pointes; AV; atrioventricular; CiPA; Comprehensive In-Vitro Proarrhythmia Assay; CSRC; Cardiac Safety Research Consortium; DG; Discussion
Cardiologist's point of view: Novel ECG biomarkers and in silico models for proarrhythmic risk prediction: Are we ready?
Keywords: پرواریتریوم; QT prolongation; hERG channel; Proarrhythmia; Torsades de pointes;
Points to consider for a validation study of iPS cell-derived cardiomyocytes using a multi-electrode array system
Keywords: پرواریتریوم; Cardiac safety pharmacology; Human iPS cells; JiCSA; Multi-electrode array; Proarrhythmia; Standardization;
New in vitro model for proarrhythmia safety screening: IKs inhibition potentiates the QTc prolonging effect of IKr inhibitors in isolated guinea pig hearts
Keywords: پرواریتریوم; ECG; Guinea pig hearts; Langendorff perfusion; Methods; Proarrhythmia; Rate corrected QT interval; Repolarization reserve; Safety screening; Synergism; Torsades de pointes;
Small-conductance Ca2+-activated K+ channels and cardiac arrhythmias
Keywords: پرواریتریوم; AERP; atrial effective refractory period; AF; atrial fibrillation; AP; action potential; APD; action potential duration; CaM; calmodulin; CK2; casein kinase II; EAD; early afterdepolarization; HF; heart failure; MLC2; myosin light chain-2; PP2A; protein p
Vernakalant in an Experimental Model of Pacing-Induced Heart Failure: Lack of Proarrhythmia Despite Prolongation of Repolarization
Keywords: پرواریتریوم; Vernakalant; heart failure; dispersion of repolarization; polymorphic ventricular tachycardia; proarrhythmia
Dofetilide induced torsade de pointes: Mechanism, risk factors and management strategies
Keywords: پرواریتریوم; Dofetilide; Torsade de Pointes; Proarrhythmia; QT prolongation; Atrial fibrillation;
Pharmacology and Toxicology of Nav1.5-Class 1 Antiarrhythmic Drugs
Keywords: پرواریتریوم; Sodium channel; Drugs; Proarrhythmia;
Paradoxical long-term proarrhythmic effects after ablating the “head station” ganglionated plexi of the vagal innervation to the heart
Keywords: پرواریتریوم; AF; atrial fibrillation; AT; atrial tachycardia; AV; atrioventricular; ECANS; extrinsic cardiac autonomic nervous system; ERP; effective refractory period; GP; ganglionated plexi; HFS; high-frequency stimulation; ICANS; intrinsic cardiac autonomic nervous
Electrical storm after cardiac resynchronization therapy in a patient with nonischemic cardiomyopathy: Signal-averaged vector-projected 187-channel electrocardiogram-based risk stratification for lethal arrhythmia
Keywords: پرواریتریوم; CRT; Proarrhythmia; RTc dispersion; Tpeak-end dispersion
Characteristics of atrial tachycardia due to small vs large reentrant circuits after ablation of persistent atrial fibrillation
Keywords: پرواریتریوم; AF, atrial fibrillation; AT, atrial tachycardia; CS, coronary sinus; ECG, electrocardiogram; LA, left atrium/atrial; PV, pulmonary vein; RF, radiofrequencyAtrial tachycardia; Atrial fibrillation; Catheter ablation; Linear ablation; Proarrhythmia
The use of serum bepridil concentration as a safe rhythm control strategy in patients with atrial tachyarrhythmias
Keywords: پرواریتریوم; Serum concentration; Atrial tachyarrhythmia; QT interval; QTc; Proarrhythmia
Drug-induced QT-interval shortening following antiepileptic treatment with oral rufinamide
Keywords: پرواریتریوم; Drug-induced QT-interval shortening; Short QT syndrome; SUDEP; sudden cardiac death; Proarrhythmia; RufinamideAED, antiepileptic drugs; ECG, electrocardiogram/electrocardiographic; IKr, delayed rectifier potassium current; INa, sodium channel current; LGS
Postablation Atrial Flutters
Keywords: پرواریتریوم; Catheter ablation; Atrial flutter; Atrial fibrillation; Atrial tachycardia; Proarrhythmia;
Ventricular rate adaptation: A novel, rapid, cellular-based in-vitro assay to identify proarrhythmic and torsadogenic compounds
Keywords: پرواریتریوم; Alternans; Proarrhythmia; QT; Rate-adaptation; Refractoriness; Torsades-de-Pointes
Ventricular Tachycardia After Implantable Cardioverter-Defibrillator Placement
Keywords: پرواریتریوم; Catheter ablation; Implantable converter-defibrillator; Ventricular tachycardia; Proarrhythmia;
Antiarrhythmic Drugs: Age, Race, and Gender Effects
Keywords: پرواریتریوم; Antiarrhythmic drugs; Proarrhythmia; Atrial fibrillation; Women; Elderly; Race; Pregnancy;
Aggravation of Arrhythmia by Antiarrhythmic Drugs (Proarrhythmia)
Keywords: پرواریتریوم; Antiarrhythmic drugs; Aggravation of arrhythmic; Proarrhythmia; Prolonged QT interval; Torsade des pointes;
The isolated rabbit heart and Purkinje fibers as models for identifying proarrhythmic liability
Keywords: پرواریتریوم; Action potential; Langendorff isolated heart; Preclinical models; Proarrhythmia; Purkinje fiber; QT prolongation; Rabbit;
Ventricular fibrillation induced by double premature ventricular pacing stimuli in a dual-chamber pacemaker with AutoCapture
Keywords: پرواریتریوم; Ventricular fibrillation; Pacing; Proarrhythmia;
Giant T–U Waves Precede Torsades de Pointes in Long QT Syndrome : A Systematic Electrocardiographic Analysis in Patients With Acquired and Congenital QT Prolongation
Keywords: پرواریتریوم; ECG; U-wave; proarrhythmia; torsades de pointesa-LQTS, acquired long QT syndrome; c-LQTS, congenital long QT syndrome; EAD, early afterdepolarization; ECG, electrocardiogram; LQTS, long QT syndrome; PVC, premature ventricular complex; TdP, torsades de poi
Drugs and Brugada syndrome patients: Review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org)
Keywords: پرواریتریوم; Brugada syndrome; Drugs; Adverse effects; Proarrhythmia; Antiarrhythmic drug; Sudden cardiac deathACC, American College of Cardiology; AHA, American Heart Association; ECG, electrocardiogram; ESC, European Society of Cardiology
Significance of QRS prolongation during diagnostic ajmaline test in patients with suspected Brugada syndrome
Keywords: پرواریتریوم; Brugada syndrome; Ajmaline test; QRS prolongation; Proarrhythmia; Class I drugs; Ventricular arrhythmias; Conduction defects
Implantable Cardioverter-Defibrillator Therapy for Primary Prevention of Sudden Cardiac Death: An Argument for Restraint
Keywords: پرواریتریوم; Defibrillator; Ventricular tachycardia; Sudden death; Primary prevention; Proarrhythmia; Cost-effectiveness;
Inappropriate Implantable Cardioverter-Defibrillator Therapy
Keywords: پرواریتریوم; Inappropriate shock; Antitachycardia therapy; Implantable cardioverter-defibrillator; Ventricular arrhythmia; Atrial arrhythmia; Sinus tachycardia; Supraventricular tachycardia discrimination; Proarrhythmia; Oversensing;
Wide complex tachycardia in a patient with paroxysmal atrial fibrillation
Keywords: پرواریتریوم; Atrial fibrillation; Pacemaker-mediated tachycardia; Proarrhythmia;
Use and abuse of QT and TRIaD in cardiac safety research: Importance of study design and conduct
Keywords: پرواریتریوم; Drug safety; QT-liability; Repolarization disturbances; Good Laboratory Practice; Proarrhythmia
A Critical Appraisal of Implantable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death
Keywords: پرواریتریوم; defibrillator; trials; sudden death; proarrhythmia; cost-effectivenessCI, confidence interval; CRT, cardiac resynchronization therapy; EF, ejection fraction; HR, hazard ratio; ICD, implantable cardioverter-defibrillator; NYHA, New York Heart Association;
Impact of study design on proarrhythmia prediction in the SCREENIT rabbit isolated heart model
Keywords: پرواریتریوم; hERG; Methods; Proarrhythmia; QT prolongation; Safety margin; SCREENIT rabbit isolated heart model; Torsades de Pointes; TRIad
Monitoring of QT interval in patients treated with psychotropic drugs
Keywords: پرواریتریوم; Drug induced long QT syndrome; Proarrhythmia; Psychotropic drugs; QT interval
New concepts for old drugs to maintain sinus rhythm in patients with atrial fibrillation
Keywords: پرواریتریوم; Atrial fibrillation; Drug therapy; Pathophysiological concept; Proarrhythmia; Drug safety; Rhythm control
Further evidence of inherited long QT syndrome gene mutations in antiarrhythmic drug–associated torsades de pointes
Keywords: پرواریتریوم; LQTS; Torsades de pointes; Proarrhythmia; Amiodarone; Ion-channel mutation
Arrhythmias associated with fluoroquinolone therapy
Keywords: پرواریتریوم; Proarrhythmia; QT prolongation; Torsades de pointes; Ciprofloxacin; Ofloxacin; Levofloxacin; Gemifloxacin; Moxifloxacin
A gender-independent proarrhythmic action of 17β-estradiol in anaesthetized rabbits
Keywords: پرواریتریوم; Arrhythmia; Estradiol; Estrogen; Gender; Long QT syndrome; Proarrhythmia; Repolarization; Sex hormone; Torsade de pointes;
Importance of extracardiac α1-adrenoceptor stimulation in assisting dofetilide to induce torsade de pointes in rabbit hearts
Keywords: پرواریتریوم; Ventricular stretch; α1-Adrenergic receptor; Repolarization prolongation; Torsade de pointes; Proarrhythmia; QT interval
Safe and effective conversion of persistent atrial fibrillation to sinus rhythm by intravenous AZD7009
Keywords: پرواریتریوم; Antiarrhythmic drug; Atrial fibrillation; Atrial flutter; AZD7009; Proarrhythmia; Sinus rhythm